Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trastuzumab in HER2-positive pretreated NSCLC (MO20509)
2007-003709-29Phase 2Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Jul 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trastuzumab in non-small cell lung cancer (NSCLC), sponsored by Humanitas Research Hospital. Primary endpoint: Response rate. Started Jul 2008; status: terminated.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-003709-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003709-29.